Molecular Pathways in Emerging Viral Diseases

Virology Today, 2022

Abstract

Emerging viral diseases represent one of the most significant global threats to human and animal health. Understanding the molecular pathways that govern viral infection, replication, and immune evasion is fundamental to controlling outbreaks and designing effective therapeutics. This article reviews recent advances in elucidating the molecular mechanisms underlying emerging viral pathogens, including coronaviruses, flaviviruses, and filoviruses. We discuss key cellular signaling pathways exploited by viruses, the host responses they trigger, and the molecular determinants of virulence and transmission. Integrative approaches combining molecular virology, systems biology, and structural genomics are reshaping our comprehension of viral pathogenesis and offering novel targets for antiviral intervention.

Introduction

The past two decades have witnessed the emergence and re-emergence of numerous viral diseases—SARS, MERS, COVID-19, Zika, Ebola, and Nipah—underscoring the vulnerability of global health systems to viral threats. While epidemiological surveillance has advanced, our ability to mitigate viral spread and pathogenicity hinges on a deep molecular understanding of how viruses interact with host cellular machinery.

Emerging viruses often exploit conserved molecular pathways to establish infection, subvert immune detection, and ensure replication. By mapping these pathways, researchers can identify shared mechanisms that transcend viral families, providing a foundation for developing broad-spectrum antivirals and universal vaccine strategies.

Key Molecular Pathways and Mechanisms

1. Viral Entry and Host Receptor Interactions

Emerging viruses initiate infection through precise interactions between viral surface proteins and host cell receptors. For example, SARS-CoV-2 uses ACE2 and TMPRSS2 for cell entry, while Ebola virus engages NPC1 and TIM-1. Structural and biochemical studies reveal how receptor-binding domains evolve to enhance affinity and expand host range, often dictating zoonotic potential.

2. Intracellular Replication Complexes

Once internalized, viruses remodel host membranes to create replication organelles. Positive-sense RNA viruses such as flaviviruses and coronaviruses form double-membrane vesicles that protect viral RNA from host sensors. Advanced imaging and proteomics have identified key viral nonstructural proteins that orchestrate these microenvironments, including the coronavirus NSP3-NSP4 complex.

3. Modulation of Innate Immune Signaling

Emerging viruses have evolved numerous strategies to suppress antiviral signaling pathways. Viral proteins frequently target the interferon (IFN) response by degrading pattern-recognition receptors (RIG-I, MDA5) or blocking downstream kinases (TBK1, IRF3). SARS-CoV-2 ORF6 and Ebola VP35 exemplify such antagonists, impairing host transcriptional antiviral responses.

4. Hijacking of Host Metabolism

Viral replication imposes significant metabolic demands. Recent metabolomic profiling has shown that viruses reprogram host lipid and nucleotide biosynthesis pathways to support virion assembly. For instance, dengue virus activates the SREBP pathway to enhance lipid droplet formation, while influenza viruses manipulate glycolytic flux to fuel rapid replication.

5. Apoptosis and Cell Survival Pathways

Control of programmed cell death is a hallmark of viral pathogenesis. Some viruses, such as Zika and Nipah, induce apoptosis to facilitate dissemination, while others inhibit apoptosis to prolong replication cycles. Understanding these opposing strategies has unveiled therapeutic entry points for modulating host survival signaling during infection.

6. Cross-Talk Between Viral and Host Signaling Networks

Systems-level analyses reveal that viruses perturb interconnected host networks, including MAPK, PI3K-AKT, and NF-κB pathways. These perturbations are not random but reflect finely tuned mechanisms evolved to optimize viral propagation while minimizing immune detection.

Emerging Tools and Integrative Approaches

Advances in omics technologies—transcriptomics, proteomics, metabolomics—have enabled comprehensive mapping of virus-host interactions. CRISPR-based genetic screens are now identifying essential host factors for viral replication, while cryo-electron microscopy provides atomic-level visualization of viral complexes. Machine learning applied to these datasets is uncovering conserved molecular signatures across viral families, paving the way for predictive modeling of future pathogens.

Conclusion

The study of molecular pathways in emerging viral diseases bridges fundamental virology and translational medicine. By dissecting how viruses exploit host systems, researchers can reveal common vulnerabilities that inform the next generation of therapeutics and vaccines. Continued investment in molecular surveillance, structural biology, and integrative systems approaches will be crucial for anticipating and mitigating future viral threats.

Keywords

Emerging viruses · Molecular pathways · Host–virus interactions · Immune evasion · Signal transduction · Systems virology · Antiviral targets · Pathogenesis